Tax experts offer insight into the various government efforts to prevent inversions. Will these measures halt such transactions in the medtech space?
Ori Epstein, Robert Verzi, and Philip Brudney
About a year and a half ago, the pending mega-merger of Covidien and Medtronic was the talk of the medical device industry and, more broadly, the M&A world. The merger would have formed a medical device giant and been one of the largest mergers ever accomplished in the medical device industry.
Amidst all the buzz in the medical device community, there was a different type of buzz growing in our nation’s capital. The Treasury Department, Congress, and the president were all interested in the pending deal for an entirely different reason. The merger was...